16. Other non-current assets
Other non-current assets consisted of following items:
|
31 December |
|
|---|---|---|
(thousands of €) |
2023 |
2022 |
Non-current restricted cash |
5,533 |
4,569 |
Financial assets held at fair value through profit or loss |
13,575 |
- |
Non-current portion of upfront payment to NovAlix |
4,656 |
- |
Non-current portion of advance related to the NovAliX transaction |
5,563 |
- |
Other non-current assets |
318 |
1,209 |
Total other non-current assets |
29,645 |
5,778 |
Financial assets held at fair value through profit or loss at 31 December 2023 consisted of an equity instrument of a non-listed company. We have no restrictions on the sale of this equity instrument and the asset is not pledged under any of our liabilities. The fair value of this equity instrument was determined by reference to the initial transaction price (classified as level 3 in the fair value hierarchy).
We refer to note 28 “Details of the NovAlix transaction” for more information related to the upfront payment and advance.